VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow
Authors:
- 12 June 2016
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 174 (6) , 970-982
Abstract
Summary: Very Late Antigen‐4 (VLA‐4, α4β1‐integrin, ITGA4) orchestrates cell‐cell and cell‐endothelium adhesion. Given the proposed role of VLA‐4 in sickle cell disease (SCD) pathophysiology, we evaluated the ability of the VLA‐4 blocking antibody natalizumab to inhibit SCD blood cell adhesion. Natalizumab recognized surface VLA‐4 on leucocytes and reticulocytes in whole blood from SCD subjects. SCD reticulocytes were positive for VLA‐4, while VLA‐4 staining of non‐SCD reticulocytes was undetectable. Titrations with natalizumab revealed the presence of saturable levels of VLA‐4 on both SCD reticulocytes and leucocytes similar to healthy subject leucocytes. Under physiological flow conditions, the adhesion of SCD whole blood cells and isolated SCD leucocytes to immobilized vascular cell adhesion molecule 1 (VCAM‐1) was blocked by natalizumab in a dose‐dependent manner, which correlated with cell surface receptor binding. Natalizumab also inhibited >50% of whole blood cell binding to TNF‐α activated human umbilical vein endothelial cell monolayers under physiological flow at clinically relevant concentrations (10 to 100 μg/ml). This indicates that VLA‐4 is the dominant receptor that drives SCD reticulocyte and mononuclear cell adhesion to VCAM‐1 and that the VLA‐4 adhesion to VCAM‐1 is a significant contributor to SCD blood cell adhesion to endothelium. Thus, VLA‐4 blockade may be beneficial in sickle cell disease.Keywords
Funding Information
- Biogen
This publication has 56 references indexed in Scilit:
- Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple SclerosisPLOS ONE, 2012
- Erythrocyte plasma membrane–bound ERK1/2 activation promotes ICAM-4–mediated sickle red cell adhesion to endotheliumBlood, 2012
- Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatinHaematologica, 2010
- Severe sickle cell anemia is associated with increased plasma levels of TNF‐R1 and VCAM‐1American Journal of Hematology, 2010
- GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell miceBlood, 2010
- Aggregation of mononuclear and red blood cells through an 4 1-Lu/basal cell adhesion molecule interaction in sickle cell diseaseHaematologica, 2010
- Sickle red cells induce adhesion of lymphocytes and monocytes to endotheliumBlood, 2008
- Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domainTranslational Research, 2008
- Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytesBlood, 2008
- Erythrocyte Adherence to Endothelium in Sickle-Cell AnemiaNew England Journal of Medicine, 1980